Pfizer Inc (NYSE: PFE) has reported E.P.S. of $0.55 for its first fiscal quarter (ending March 31) versus $0.98 for the same period a year ago — a decline of -44%. This performance was $-0.15 […]
For its second fiscal quarter (ending March 31), PTC Inc (NASDAQ: PTC) has reported a 78% increase in E.P.S. from $0.54 a year ago to $0.96 in the current quarter. Relative to the consensus estimate […]
Stock Rating Upgrade Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for OraSure Technologies Inc (NASDAQ: OSUR) improved during the last several trading days. OSUR’s current Value Trend Rating is C and […]
OncoGenex Pharmaceuticals Inc (NASDAQ: VRSK) has reported earnings for its first fiscal quarter (ending March 31) of $1.53 versus $1.28 for the same period a year ago — an increase of 20%. However, this result […]
Norwegian Cruise Line Holdings L (NYSE: NCLH) has reported E.P.S. of $0.04 for its first fiscal quarter (ending March 31) versus $-0.38 for the same period a year ago. This performance was $-0.13 short of […]
On 5/1/24, MiMedx Group Inc (NASDAQ: MDXG) stock enjoyed a major increase of 18.7%, closing at $7.31. Moreover, exceptionally high trading volume at 252% of normal accompanied the advance. The stock has performed in line […]
Stock Rating Upgrade The Value Trend Rating for Mercury General Corp (NYSE: MCY) improved recently from C to B reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in our […]
For its first fiscal quarter (ending March 31), LivaNova PLC (NASDAQ: LIVN) has reported a -657% decline in E.P.S. from $0.14 a year ago to $-0.78 in the current quarter. Relative to the consensus estimate […]
Stock Rating Downgrade During the last several trading days the Value Trend Rating for Kosmos Energy Ltd (NYSE: KOS) weakened from B to C reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action On […]
Stock Rating Downgrade The Value Trend Rating for Koninklijke Philips NV (NYSE: PHG) weakened of late from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research